Bio-Intervention Specialists (Bio-IS) and HSS Inc. (HSS) announce that their companies have signed a five-year partnership to deliver the Bio-Intervention Disinfection Service to hospitals across the United States.
 Â
Bio-IS has launched the newly EPA-registered Electro-BioCide disinfectant and its Bio-Intervention protocol into the U.S. healthcare market. HSS is one of the nations leading healthcare outsourcing companies, having been ranked by Modern Healthcare as the sixth largest in the industry. Together, HSS and Bio-IS will provide hospitals the Bio-Intervention Disinfection Service, a 21st century solution to the challenge of hard-surface disinfection.
Â
Today, most hospitals follow the same approach to hard surface disinfection as they have for the past 35 years; a housekeeper, using a spray bottle and rag. Through the power of Mother Nature and mutation, this legacy approach is no longer effective against the superbugs of the 21st century.
Â
Utilizing the newly EPA-registered Electro-BioCide disinfectant, the companies have certified Bio-Intervention Technicians that use portable electrostatic sprayers to comprehensively disinfect the hard surfaces of hospitals and healthcare facilities using a specific, step-by-step, protocol. This combination of skilled specialists and innovative technology solves the current weak links of hard surface infection control.
Â
We are very excited about this partnership because of the outstanding reputation of HSS and their 90 percent-plus customer retention rates," says Tom Boyer, president and CEO of Bio-IS. "Their commitment to quality is second to none and we are honored to have them as our partner. Both companies are truly committed to saving lives and reducing costs through the Bio-Intervention Disinfection Service.
Â
Reducing hospital-acquired infections will save lives and reduce costs, says Wayne Schell, CEO of HSS. We are pleased to partner with Bio-IS to deliver a solution that will help healthcare providers combat these deadly and costly infections.
Â
This service is currently available in 35 states. The companies expect complete national coverage in early 2011. Teams are available for either emergent or continuous on-site deployment. For more information, call (800) 699-4230.
Â
Â
Vet IP Roundtable 2: Infection Control and Biosecurity Challenges in Veterinary Care
March 31st 2025Veterinary IPs highlight critical gaps in cleaning protocols, training, and biosecurity, stressing the urgent need for standardized, animal-specific infection prevention practices across diverse care settings.
Invisible, Indispensable: The Vital Role of AHRQ in Infection Prevention
March 25th 2025With health care systems under strain and infection preventionists being laid off nationwide, a little-known federal agency stands as a last line of defense against preventable patient harm. Yet the Agency for Healthcare Research and Quality (AHRQ) is now facing devastating cuts—threatening decades of progress in patient safety.
The Sterile Processing Conference Survival Guide: How to Make the Most of Your Next Event
March 25th 2025From expert speakers to cutting-edge tools, sterile processing conferences, like the 2025 HSPA Annual Conference and the SoCal SPA's Spring Conference, offer unmatched opportunities to grow your skills, expand your network, and strengthen your department's infection prevention game.
Redefining Material Compatibility in Sterilization: Insights From AAMI TIR17:2024
March 24th 2025AAMI TIR17:2024 provides updated, evidence-based guidance on material compatibility with sterilization modalities. It offers essential insights for medical device design and ensures safety without compromising functionality.